These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 37742915)
1. Effectiveness of vagus nerve stimulation for drug-resistant generalized epilepsy in children aged six and younger. Lyu J; Wang JB; Quan Y; Zhang X; Gong SP; Qu JQ; Huang SP Neurochirurgie; 2023 Nov; 69(6):101500. PubMed ID: 37742915 [TBL] [Abstract][Full Text] [Related]
2. The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis. Hajtovic S; LoPresti MA; Zhang L; Katlowitz KA; Kizek DJ; Lam S J Neurosurg Pediatr; 2022 Jun; 29(6):667-680. PubMed ID: 35303699 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety following two or more years of vagus nerve stimulation (VNS Therapy) in pediatric patients with drug-resistant epilepsy enrolled in a Russian VNS Registry. Feygina AA; Koshelyaevskaya YN; Dibué M; Voronkova KV; Klochkov MN; Koroleva NY; Ivanov SS; Bolshakova ES; Fatykhova EF Brain Behav; 2023 Jul; 13(7):e3076. PubMed ID: 37254623 [TBL] [Abstract][Full Text] [Related]
4. Combined Neuromodulation (Vagus Nerve Stimulation and Deep Brain Stimulation) in Patients With Refractory Generalized Epilepsy: An Observational Study. Cukiert A; Cukiert CM; Burattini JA; Guimaraes RB Neuromodulation; 2023 Dec; 26(8):1742-1746. PubMed ID: 36109334 [TBL] [Abstract][Full Text] [Related]
5. Postoperative seizure freedom after vagus nerve stimulator placement in children 6 years of age and younger. Maleknia P; McWilliams TD; Barkley A; Estevez-Ordonez D; Rozzelle C; Blount JP J Neurosurg Pediatr; 2023 Apr; 31(4):329-332. PubMed ID: 36670534 [TBL] [Abstract][Full Text] [Related]
6. Quality-of-life metrics with vagus nerve stimulation for epilepsy from provider survey data. Englot DJ; Hassnain KH; Rolston JD; Harward SC; Sinha SR; Haglund MM Epilepsy Behav; 2017 Jan; 66():4-9. PubMed ID: 27974275 [TBL] [Abstract][Full Text] [Related]
7. A prospective long-term study on the outcome after vagus nerve stimulation at maximally tolerated current intensity in a cohort of children with refractory secondary generalized epilepsy. Cukiert A; Cukiert CM; Burattini JA; Lima AM; Forster CR; Baise C; Argentoni-Baldochi M Neuromodulation; 2013; 16(6):551-6; discussion 556. PubMed ID: 23738578 [TBL] [Abstract][Full Text] [Related]
8. Vagus nerve stimulation in patients with therapy-resistant generalized epilepsy. Suller Marti A; Mirsattari SM; MacDougall K; Steven DA; Parrent A; de Ribaupierre S; Andrade A; Diosy D; McLachlan RS; Burneo JG Epilepsy Behav; 2020 Oct; 111():107253. PubMed ID: 32615417 [TBL] [Abstract][Full Text] [Related]
9. Use of Vagus Nerve Stimulator on Children With Primary Generalized Epilepsy. Welch WP; Sitwat B; Sogawa Y J Child Neurol; 2018 Jun; 33(7):449-452. PubMed ID: 29651891 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of vagus nerve stimulation for drug-resistant epilepsy in children age six and younger. Muthiah N; Zhang J; Remick M; Welch W; Sogawa Y; Jeong JH; Abel TJ Epilepsy Behav; 2020 Nov; 112():107373. PubMed ID: 32942207 [TBL] [Abstract][Full Text] [Related]
11. Outcome of vagus nerve stimulation for drug-resistant epilepsy: the first three years of a prospective Japanese registry. Kawai K; Tanaka T; Baba H; Bunker M; Ikeda A; Inoue Y; Kameyama S; Kaneko S; Kato A; Nozawa T; Maruoka E; Osawa M; Otsuki T; Tsuji S; Watanabe E; Yamamoto T Epileptic Disord; 2017 Sep; 19(3):327-338. PubMed ID: 28832004 [TBL] [Abstract][Full Text] [Related]
12. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States. Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763 [TBL] [Abstract][Full Text] [Related]
13. Vagus nerve stimulation for partial and generalized epilepsy from infancy to adolescence. Thompson EM; Wozniak SE; Roberts CM; Kao A; Anderson VC; Selden NR J Neurosurg Pediatr; 2012 Sep; 10(3):200-5. PubMed ID: 22768964 [TBL] [Abstract][Full Text] [Related]
15. Safety of vagus nerve stimulation and responsive neurostimulation used in combination for multifocal and generalized onset epilepsy in pediatric patients. Beaudreault CP; Spirollari E; Naftchi AF; Sukul V; Das A; Vazquez S; Wolf SM; McGoldrick PE; Muh CR J Neurosurg Pediatr; 2023 Jun; 31(6):565-573. PubMed ID: 36933267 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Vagal Nerve Stimulation for Drug-Resistant Epilepsy: Is it the Stimulation or Medication? Arcand J; Waterhouse K; Hernandez-Ronquillo L; Vitali A; Tellez-Zenteno JF Can J Neurol Sci; 2017 Sep; 44(5):532-537. PubMed ID: 28862106 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of vagus nerve stimulation in 95 children of drug-resistant epilepsy with structural etiology. Xie H; Ma J; Ji T; Liu Q; Cai L; Wu Y Epilepsy Behav; 2023 Mar; 140():109107. PubMed ID: 36758359 [TBL] [Abstract][Full Text] [Related]
18. Is thalamic deep brain stimulation synergistic with vagus nerve stimulation in drug-resistant genetic generalized epilepsy? Khan A; Middlebrooks EH; Freund B; Grewal S; Tatum WO Epileptic Disord; 2023 Jun; 25(3):406-409. PubMed ID: 36938890 [TBL] [Abstract][Full Text] [Related]
19. Vagus nerve stimulation for children with treatment-resistant epilepsy: a consecutive series of 141 cases. Elliott RE; Rodgers SD; Bassani L; Morsi A; Geller EB; Carlson C; Devinsky O; Doyle WK J Neurosurg Pediatr; 2011 May; 7(5):491-500. PubMed ID: 21529189 [TBL] [Abstract][Full Text] [Related]
20. Anterior Nucleus of the Thalamus Deep Brain Stimulation with Concomitant Vagus Nerve Stimulation for Drug-Resistant Epilepsy. Parisi V; Lundstrom BN; Kerezoudis P; Alcala Zermeno JL; Worrell GA; Van Gompel JJ Neurosurgery; 2021 Sep; 89(4):686-694. PubMed ID: 34333659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]